This study aims to demonstrate the safety and efficacy of the SELUTION SLR™ 018 DEB compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
3 Primary · 0 Secondary · Reporting Duration: 12 months
300 Total Participants · 2 Treatment Groups
Primary Treatment: SELUTION SLR™ 018 DEB · No Placebo Group · N/A
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: